logo
  

Atlas Air Worldwide Names John Dietrich President & COO Of Atlas Air Inc.

Atlas Air Worldwide Holdings Inc. (AAWW) announced it has appointed John Dietrich as President and Chief Operating Officer (COO) of Atlas Air, Inc., the company's wholly owned subsidiary, effective October 15. Dietrich will retain his role with the parent holding company.

Dietrich joined the company in 1999 as Associate General Counsel. He was promoted to Vice President and General Counsel in 2003, and in 2004 was promoted to Senior Vice President, General Counsel and Corporate Secretary. Dietrich was appointed Executive Vice President and Chief Operating Officer of Atlas Air Worldwide in 2006.

The company also announced the appointment of Michael Steen as President and CEO of the company's wholly owned dry-leasing subsidiary, Titan Aviation Holdings, Inc., effective October 15. Steen will continue in his current role as Executive Vice President and Chief Commercial Officer of the parent holding company and Atlas Air, Inc.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT